In various ALT + malignancies, where the average survival is inferior to that of non-ALT counterparts and the cancers display predominant resistance to conventional chemotherapeutic treatments, recognizing these targets and subsequently developing or repurposing therapies for them may be crucial for enhancing the prognosis [3]. Here, GPT is linked to cancer.